Gara Jalqabaatti › Lymphoma Selii Mantle
Qorannoo klinikaalii Lymphoma Selii Mantle Ameerikaa Keessatti hirmaatuu
Qorannoo 70 Lymphoma Selii Mantle f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Houston, TXQorannoo 15
- Baldwin Park, CAQorannoo 15
- Durham, NCQorannoo 13
- New York City, NYQorannoo 12
- Seattle, WAQorannoo 12
- Milwaukee, WIQorannoo 12
- Boston, MAQorannoo 11
- Nashville, TNQorannoo 11
- Columbus, OHQorannoo 11
- Chicago, ILQorannoo 10
- Rochester, MNQorannoo 9
- Portland, ORQorannoo 9
- Atlanta, GAQorannoo 8
- Denver, COQorannoo 8
- St. Louis, MOQorannoo 8
- Mountain View, CAQorannoo 7
- Los Angeles, CAQorannoo 7
- Cleveland, OHQorannoo 7
- Miami, FLQorannoo 6
- Jacksonville, FLQorannoo 6
- Ann Arbor, MIQorannoo 6
- Dallas, TXQorannoo 6
- Salt Lake City, UTQorannoo 6
- Buffalo, NYQorannoo 5
- Washington, DCQorannoo 5
- San Diego, CAQorannoo 5
- Tampa, FLQorannoo 5
- New Haven, CTQorannoo 5
- Baltimore, MDQorannoo 5
- Kansas City, MOQorannoo 5
- Charlotte, NCQorannoo 5
- Philadelphia, PAQorannoo 5
- Edison, NJQorannoo 5
- Cedar Rapids, IAQorannoo 4
- Richmond, VAQorannoo 4
- Birmingham, ALQorannoo 4
- Pittsburgh, PAQorannoo 4
- Minneapolis, MNQorannoo 4
- Omaha, NEQorannoo 4
- Queens, NYQorannoo 4
Naannoon
- AlabamaQorannoo 4
- ArizonaQorannoo 6
- CaliforniaQorannoo 29
- ColoradoQorannoo 10
- ConnecticutQorannoo 6
- DelawareQorannoo 3
- FloridaQorannoo 16
- GeorgiaQorannoo 9
- IllinoisQorannoo 10
- IndianaQorannoo 4
- IowaQorannoo 5
- KansasQorannoo 7
- KentuckyQorannoo 4
- LouisianaQorannoo 3
- MarylandQorannoo 9
- MassachusettsQorannoo 13
- MichiganQorannoo 8
- MinnesotaQorannoo 14
- MissouriQorannoo 8
- NebraskaQorannoo 4
- New JerseyQorannoo 8
- New YorkQorannoo 16
- North CarolinaQorannoo 17
- OhioQorannoo 16
- OregonQorannoo 9
- PennsylvaniaQorannoo 9
- Rhode IslandQorannoo 4
- TennesseeQorannoo 12
- TexasQorannoo 19
- UtahQorannoo 6
- VirginiaQorannoo 7
- WashingtonQorannoo 14
- WisconsinQorannoo 13
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05006716Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05976763Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07763210Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 110 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05724121Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06252675The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07285044A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06542250A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06697184A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06742996Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06553872Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06784167A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07101328Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06029309Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07003295Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07225439A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06564038A Study of ARC-02 in B-cell NHL
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07691606Nemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT07673367AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT06340737Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT05887167LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 81 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT05990465Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 13 hanga 90 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06533579Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT06675123A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT07424833This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT07121946Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.